Literature DB >> 22776443

A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed?

George I Eluwa1, Steffanie A Strathdee, Samson B Adebayo, Babatunde Ahonsi, Sylvia B Adebajo.   

Abstract

OBJECTIVE: Injecting drug use is now recognized as a significant risk factor for HIV in sub-Saharan Africa. We evaluated prevalence and correlates of HIV among injecting drug users (IDUs) in Nigeria.
METHODS: A cross sectional design using respondent driven sampling was conducted in six states in 2010. Weighted HIV prevalence and injecting risk behaviors calculated using RDS analytic tool. Logistic regression was used to determine correlates of HIV infection, stratified by state.
RESULTS: Total numbers of IDUs ranged from 197 in Lagos to 273 in Cross River and Oyo states. HIV prevalence was highest in Federal Capital Territory (FCT) at 9.3%, Kaduna 5.8%, Oyo 5.1%, Kano 4.9%, CR 3.3% and Lagos 3.0%. Although >90% of participants were male, females had higher HIV prevalence in all states surveyed except FCT (range: 7.4% in CR to 37.7% in Kano). Logistic regression showed that females were significantly more likely to be HIV positive in Kano [OR=33.2, 95% CI: 6.8-160.4], Oyo [AOR=15.9, 95% CI: 3.69-68.51], Lagos [OR=15.5, 95% CI: 2.41-99.5] and Kaduna states [AOR=19.6, 95% CI: 4.4-87.6]. For injecting risk behavior, only receptive sharing was associated with HIV [AOR=7.6, 95% CI: 1.2-48.7] and [AOR=0.2, 95% CI: 0.04-0.92] in Oyo and Kaduna states respectively.
CONCLUSIONS: Considerable heterogeneity in the prevalence of HIV and associated risk behaviors exist among IDUs across Nigeria. Females had higher HIV prevalence among IDUs in five of six states, suggesting a need for targeted interventions for this hidden subgroup. Further research is needed to understand HIV transmission dynamics of IDUs in Nigeria. Community-based opioid substitution therapy and needle exchange programs should be implemented without delay.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22776443     DOI: 10.1016/j.drugalcdep.2012.06.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  14 in total

Review 1.  Drug use as a driver of HIV risks: re-emerging and emerging issues.

Authors:  Nabila El-Bassel; Stacey A Shaw; Anindita Dasgupta; Steffanie A Strathdee
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

Review 2.  Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.

Authors:  Rahaman Ademolu Ahmed; Khalid Olajide Adekoya; Chika Kingsley Onwuamah; Bolanle Olufunmilayo Oboh; Smita Swaminathan Iyer; Ayomide Samuel Oluwatosin; Rosemary Ajuma Audu; Oliver Chukwujekwu Ezechi
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

Review 3.  HIV epidemic among key populations in west Africa.

Authors:  Gaston Djomand; Silas Quaye; Patrick S Sullivan
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

4.  A call to action for concentrated HIV epidemics.

Authors:  Chris Beyrer; Stefan D Baral; Brian W Weir; James W Curran; Richard E Chaisson; Patrick S Sullivan
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

5.  The Opioid Epidemic in Africa And Its Impact.

Authors:  Ann E Kurth; Peter Cherutich; Rosabelle Conover; Nok Chhun; R Douglas Bruce; Barrot H Lambdin
Journal:  Curr Addict Rep       Date:  2018-10-30

6.  "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.

Authors:  John Idoko; Morenike Oluwatoyin Folayan; Nancin Yusufu Dadem; Grace Oluwatosin Kolawole; James Anenih; Emmanuel Alhassan
Journal:  BMC Public Health       Date:  2015-04-10       Impact factor: 3.295

7.  Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.

Authors:  Annie Leprêtre; Idrissa Ba; Karine Lacombe; Maryvonne Maynart; Abdalla Toufik; Ousseynou Ndiaye; Coumba Toure Kane; Joël Gozlan; Judicaël Tine; Ibrahim Ndoye; Gilles Raguin; Pierre-Marie Girard
Journal:  J Int AIDS Soc       Date:  2015-05-22       Impact factor: 5.396

8.  HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling.

Authors:  Waimar Tun; Meredith Sheehy; Dita Broz; Jerry Okal; Nicholas Muraguri; H Fisher Raymond; Helgar Musyoki; Andrea A Kim; Mercy Muthui; Scott Geibel
Journal:  AIDS Behav       Date:  2015-02

Review 9.  A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.

Authors:  Lisa G Johnston; Avi J Hakim; Samantha Dittrich; Janet Burnett; Evelyn Kim; Richard G White
Journal:  AIDS Behav       Date:  2016-08

Review 10.  Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa.

Authors:  Erin Papworth; Nuha Ceesay; Louis An; Marguerite Thiam-Niangoin; Odette Ky-Zerbo; Claire Holland; Fatou Maria Dramé; Ashley Grosso; Daouda Diouf; Stefan D Baral
Journal:  J Int AIDS Soc       Date:  2013-12-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.